Condition-Specific Health
Lexeo LX2006 Gene Therapy Trial Targets Cardiac Endpoint in Friedreich Ataxia
The open-label study design and 6-month topline readout signal an accelerated path toward regulatory submission for the…
Condition-Specific Health 84 stories
Condition-Specific Health
Context Therapeutics Reports 29% Response Rate in PROC Phase 1 Trial
Interim RECIST v1.1 data from Context Therapeutics positions CTIM-76 as a clinical-stage candidate in a heavily pre-tre…
Condition-Specific Health
ENA Respiratory Wins USPTO Patents for TLR2 Innate Immune Modulators
The allowances cover both composition-of-matter and method-of-use claims, strengthening IP position in the emerging inn…
Condition-Specific Health
AI Radiology Model Debuts at HLTH Europe 2026
The Saudi hospital's presentation signals growing crossover between precision diagnostics and functional health monitor…
Condition-Specific Health
MHRA Clears Needle-Free Epinephrine Device for Pediatric Anaphylaxis
The MHRA approval expands emergency allergy management options for a pediatric population where needle-based delivery h…
Condition-Specific Health
Enterome's OncoMimics™ EO2463 Drives CD8 T Cell Response in Phase 1/2 Lymphoma Study
Microbiome-mimicry immunotherapy edges toward clinical validation — with implications for how gut-derived peptides may …
Condition-Specific Health
Barzolvolimab Phase 2 Data Show Durable CSU Remission Off-Treatment
Celldex's anti-KIT monoclonal antibody moves the goalposts from symptom control to potential disease modification — a s…
Condition-Specific Health
Lorundrostat Linked to Heart Failure Biomarker Reductions in Proteomic Analysis
Late-breaking findings presented at the Endocrine Society Annual Meeting add cardiovascular biomarker evidence to the a…
Condition-Specific Health
Verekitug Phase 2 Data Show 80% Responder Rate in Nasal Polyp Trial
The EAACI 2026 responder analysis adds to mounting evidence for targeted biologics in upper-airway inflammatory conditi…
Condition-Specific Health
Setmelanotide Phase 2 Data Show BMI, Fat Mass Gains in PWS
Six-month interim results reinforce MC4R pathway as a viable therapeutic target, with Phase 3 development now in the ra…
Condition-Specific Health
Pharmacist Education Targets Clinical Inertia in Type 2 Diabetes Care
As GLP-1 adoption accelerates, new CE data highlights the pharmacist's expanding role in bridging gaps between clinical…
Condition-Specific Health
Bucked Up Marks 10 Years With Sitewide Anniversary Sale
The Utah-based brand has expanded from a single deer antler spray SKU to a full portfolio spanning pre-workouts, creati…